Download Files:
CLK-IN-T3
SKU
HY-115470-10 mg
Category Reference compound
Tags Cancer, CDK;DYRK, Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
$155 – $1,650
Products Details
Product Description
– CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity[1].
Web ID
– HY-115470
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C28H30N6O2
References
– [1]Funnell T, et al. CLK-dependent exon recognition and conjoined gene formation revealed with a novel smallmolecule inhibitor. Nat Commun. 2017 Feb 23;8(1):7.
CAS Number
– 2109805-56-1
Molecular Weight
– 482.58
Compound Purity
– 98.63
SMILES
– CC(C1=CC=C(C(NC2=CN3C=C(C4=CC=NC=C4)C=CC3=N2)=O)C=C1)(C)C(N5CCN(C)CC5)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 4.83 mg/mL (ultrasonic;warming)
Target
– CDK;DYRK
Isoform
– CLK
Pathway
– Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.